The Cefpiramide sodium, with the CAS registry number 74849-93-7, is also known as 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2R)-2-[[(4-hydroxy-6-methyl-3-pyridinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,sodium salt (1:1), (6R,7R)-. This chemical's molecular formula is C25H23N8NaO7S2 and molecular weight is 634.62. What's more, its systematic name is sodium (6R,7R)-7-{[(2R)-2-(4-hydroxyphenyl)-2-{[(6-methyl-4-oxo-1,4-dihydropyridin-3-yl)carbonyl]amino}acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct -2-ene-2-carboxylate. Its classification codes are: (1)Antibacterial; (2)Drug / Therapeutic Agent; (3)Mutation data; (4)Reproductive Effect. It is a third-generation cephalosporin antibiotic.
Physical properties of Cefpiramide sodium are: (1)ACD/LogP: 0.07; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): -2.76; (4)ACD/LogD (pH 7.4): -3.64; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 15; (10)#H bond donors: 5; (11)#Freely Rotating Bonds: 10; (12)Polar Surface Area: 221.97 Å2.
You can still convert the following datas into molecular structure:
(1)SMILES: [Na+].O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)[C@@H](c3ccc(O)cc3)NC(=O)C\4=C\N\C(=C/C/4=O)C)CSc5nnnn5C)C([O-])=O
(2)Std. InChI: InChI=1S/C25H24N8O7S2.Na/c1-11-7-16(35)15(8-26-11)20(36)27-17(12-3-5-14(34)6-4-12)21(37)28-18-22(38)33-19(24(39)40)13(9-41-23(18)33)10-42-25-29-30-31-32(25)2;/h3-8,17-18,23,34H,9-10H2,1-2H3,(H,26,35)(H,27,36)(H,28,37)(H,39,40);/q;+1/p-1/t17-,18-,23-;/m1./s1
(3)Std. InChIKey: RIWWMGQFMUUYIY-ALLHVENQSA-M
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intramuscular | 1250mg/kg (1250mg/kg) | Drugs in Japan Vol. -, Pg. 578, 1990. | |
mouse | LD50 | intraperitoneal | 6400mg/kg (6400mg/kg) | Drugs in Japan Vol. -, Pg. 678, 1995. | |
mouse | LD50 | intravenous | 4300mg/kg (4300mg/kg) | Drugs in Japan Vol. -, Pg. 578, 1990. | |
mouse | LD50 | subcutaneous | 8800mg/kg (8800mg/kg) | Drugs in Japan Vol. -, Pg. 678, 1995. | |
rat | LD50 | intramuscular | > 1250mg/kg (1250mg/kg) | Drugs in Japan Vol. -, Pg. 678, 1995. | |
rat | LD50 | intraperitoneal | 12200mg/kg (12200mg/kg) | Drugs in Japan Vol. -, Pg. 578, 1990. | |
rat | LD50 | intravenous | 5850mg/kg (5850mg/kg) | Drugs in Japan Vol. -, Pg. 578, 1990. | |
rat | LD50 | oral | 12500mg/kg (12500mg/kg) | Drugs in Japan Vol. -, Pg. 578, 1990. | |
rat | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | Drugs in Japan Vol. -, Pg. 678, 1995. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View